Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world study

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD:a retrospective study of UK general practice

Chalmers, James D.
Tebboth, Abigail
Gayle, Alicia
Ternouth, Andrew
Ramscar, Nick

June 2017

Initial use of inhaled corticosteroid therapy is common in patients with Global Initiative for Chron...

The inevitable drift to triple therapy in COPD: An analysis of prescribing pathways in the UK

Brusselle, G.G. (Guy)
Price, D. (David)
Gruffydd-Jones, K. (Kevin)
Miravitlles, M. (Marc)
Keininger, D.L. (Dorothy L.)
Stewart, R. (Rebecca)
Baldwin, M. (Michael)
Jones, R.C. (Rupert C.)

January 2015

Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016

Bloom, C
Elkin, S
Quint, JK

December 2018

Background: Over the past two decades, there have been significant changes in the pharmacological ma...

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : in UK primary care: a real-world, retrospective, observational

Gruffydd-Jones, Kevin
Brusselle, Guy
Jones, Rupert
Miravitlles, Marc
Baldwin, Michael
Stewart, Rebecca
Rigazio, Anna
Davis, Emily
Keininger, Dorothy L
Price, David

January 2016

Prescribing patterns in chronic obstructive pulmonary disease (COPD) are often inconsistent with pub...

Management of COPD in the UK primary-care setting: An analysis of real life prescribing patterns

Price, David
West, Daniel
Brusselle, Guy
Gruffydd-Jones, Kevin
Jones, Rupert C.
Miravitlles, Marc
Rossi, Andrea
Hutton, Catherine
Ashton, Valerie L.
Stewart, Rebecca
Bichel, Katsiaryna

August 2014

textabstractBackground: Despite the availability of national and international guidelines, evidence ...

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

Price D
West D
Brusselle G
Gruffydd-Jones K
Jones R
Miravitlles M
Rossi A
Hutton C
Ashton VL
Stewart R
Bichel K

August 2014

David Price,1 Daniel West,2 Guy Brusselle,3–5 Kevin Gruffydd-Jones,6 Rupert Jones,7 Marc Mirav...

Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study

Kocks, Janwillem
Ferreira, António Jorge
Bakke, Per
van Schayck, Onno C.P.
Ekroos, Heikki
Tzanakis, Nikolaos
Soulard, Stéphane
Haaksma-Herczegh, Monika
Mestres-Simon, Montserrat
Águila-Fuentes, Malena
Cataldo, Didier

May 2023

This study aims to understand healthcare professionals’ thoughts and motivations about optimal manag...

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis

Pavord, I
Price, D
Miravitlles, M
Thomas, M
Wedzicha, J
Haughney, J
Bichel, K
West, D

January 2016

Clinical guidelines recommend long-acting bronchodilators as first maintenance therapy for chronic o...

First maintenance therapy for COPD in the UK between 2009 and 2012 : a retrospective database analysis

Price, David
Miravitlles, Marc
Pavord, Ian
Thomas, Mike
Wedzicha, Jadwiga
Haughney, John
Bichel, Katsiaryna
West, Daniel

November 2016

This research was conducted by Research in Real-Life Ltd (Cambridge, UK), an independent company. Me...

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.

Brusselle, G
Price, D
Gruffydd-Jones, K
Miravitlles, M
Keininger, DL
Stewart, R
Baldwin, M
Jones, RC

January 2015

BACKGROUND: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

Brusselle, Guy
Price, David
Gruffydd-Jones, Kevin
Miravitlles, Marc
Keininger, Dorothy L
Stewart, Rebecca
Baldwin, Michael
Jones, Rupert C

January 2015

Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

Annemarije L. Kruis (531151)
Björn Ställberg (531152)
Rupert C. M. Jones (531153)
Ioanna G. Tsiligianni (531154)
Karin Lisspers (531155)
Thys van der Molen (63351)
Jan Willem H. Kocks (531156)
Niels H. Chavannes (531157)

March 2014

<div><p>Background</p><p>Guideline recommendations for chronic obstructive pulmonary disease (COPD) ...

Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study.

Annemarije L Kruis
Björn Ställberg
Rupert C M Jones
Ioanna G Tsiligianni
Karin Lisspers
Thys van der Molen
Jan Willem H Kocks
Niels H Chavannes

BACKGROUND: Guideline recommendations for chronic obstructive pulmonary disease (COPD) are based on ...

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice

Chalmers, JD
Tebboth, A
Gayle, A
Ternouth, A
Ramscar, N

May 2017

Initial use of inhaled corticosteroid therapy is common in patients with Global Initiative for Chron...

The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK

Brusselle, Guy
Price, David
Gruffydd-Jones, Kevin
Miravitlles, Marc
Keininger, Dorothy L
Stewart, Rebecca
Baldwin, Michael
Jones, Rupert C

January 2015

Acknowledgments The analyses reported in this study were funded by Novartis Pharma AG (Basel, Switze...

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD:a retrospective study of UK general practice

Chalmers, James D.
Tebboth, Abigail
Gayle, Alicia
Ternouth, Andrew
Ramscar, Nick

June 2017

Initial use of inhaled corticosteroid therapy is common in patients with Global Initiative for Chron...

The inevitable drift to triple therapy in COPD: An analysis of prescribing pathways in the UK

Brusselle, G.G. (Guy)
Price, D. (David)
Gruffydd-Jones, K. (Kevin)
Miravitlles, M. (Marc)
Keininger, D.L. (Dorothy L.)
Stewart, R. (Rebecca)
Baldwin, M. (Michael)
Jones, R.C. (Rupert C.)

January 2015

Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016

Bloom, C
Elkin, S
Quint, JK

December 2018

Background: Over the past two decades, there have been significant changes in the pharmacological ma...

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : in UK primary care: a real-world, retrospective, observational

Gruffydd-Jones, Kevin
Brusselle, Guy
Jones, Rupert
Miravitlles, Marc
Baldwin, Michael
Stewart, Rebecca
Rigazio, Anna
Davis, Emily
Keininger, Dorothy L
Price, David

January 2016

Prescribing patterns in chronic obstructive pulmonary disease (COPD) are often inconsistent with pub...

Management of COPD in the UK primary-care setting: An analysis of real life prescribing patterns

Price, David
West, Daniel
Brusselle, Guy
Gruffydd-Jones, Kevin
Jones, Rupert C.
Miravitlles, Marc
Rossi, Andrea
Hutton, Catherine
Ashton, Valerie L.
Stewart, Rebecca
Bichel, Katsiaryna

August 2014

textabstractBackground: Despite the availability of national and international guidelines, evidence ...

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns

Price D
West D
Brusselle G
Gruffydd-Jones K
Jones R
Miravitlles M
Rossi A
Hutton C
Ashton VL
Stewart R
Bichel K

August 2014

David Price,1 Daniel West,2 Guy Brusselle,3–5 Kevin Gruffydd-Jones,6 Rupert Jones,7 Marc Mirav...

Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country study

Kocks, Janwillem
Ferreira, António Jorge
Bakke, Per
van Schayck, Onno C.P.
Ekroos, Heikki
Tzanakis, Nikolaos
Soulard, Stéphane
Haaksma-Herczegh, Monika
Mestres-Simon, Montserrat
Águila-Fuentes, Malena
Cataldo, Didier

May 2023

This study aims to understand healthcare professionals’ thoughts and motivations about optimal manag...

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis

Pavord, I
Price, D
Miravitlles, M
Thomas, M
Wedzicha, J
Haughney, J
Bichel, K
West, D

January 2016

Clinical guidelines recommend long-acting bronchodilators as first maintenance therapy for chronic o...

First maintenance therapy for COPD in the UK between 2009 and 2012 : a retrospective database analysis

Price, David
Miravitlles, Marc
Pavord, Ian
Thomas, Mike
Wedzicha, Jadwiga
Haughney, John
Bichel, Katsiaryna
West, Daniel

November 2016

This research was conducted by Research in Real-Life Ltd (Cambridge, UK), an independent company. Me...

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.

Brusselle, G
Price, D
Gruffydd-Jones, K
Miravitlles, M
Keininger, DL
Stewart, R
Baldwin, M
Jones, RC

January 2015

BACKGROUND: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

Brusselle, Guy
Price, David
Gruffydd-Jones, Kevin
Miravitlles, Marc
Keininger, Dorothy L
Stewart, Rebecca
Baldwin, Michael
Jones, Rupert C

January 2015

Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

Annemarije L. Kruis (531151)
Björn Ställberg (531152)
Rupert C. M. Jones (531153)
Ioanna G. Tsiligianni (531154)
Karin Lisspers (531155)
Thys van der Molen (63351)
Jan Willem H. Kocks (531156)
Niels H. Chavannes (531157)

March 2014

<div><p>Background</p><p>Guideline recommendations for chronic obstructive pulmonary disease (COPD) ...

Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study.

Annemarije L Kruis
Björn Ställberg
Rupert C M Jones
Ioanna G Tsiligianni
Karin Lisspers
Thys van der Molen
Jan Willem H Kocks
Niels H Chavannes

BACKGROUND: Guideline recommendations for chronic obstructive pulmonary disease (COPD) are based on ...

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice

Chalmers, JD
Tebboth, A
Gayle, A
Ternouth, A
Ramscar, N

May 2017

Initial use of inhaled corticosteroid therapy is common in patients with Global Initiative for Chron...

The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK

Brusselle, Guy
Price, David
Gruffydd-Jones, Kevin
Miravitlles, Marc
Keininger, Dorothy L
Stewart, Rebecca
Baldwin, Michael
Jones, Rupert C

January 2015

Acknowledgments The analyses reported in this study were funded by Novartis Pharma AG (Basel, Switze...

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD:a retrospective study of UK general practice

Chalmers, James D.
Tebboth, Abigail
Gayle, Alicia
Ternouth, Andrew
Ramscar, Nick

June 2017

Initial use of inhaled corticosteroid therapy is common in patients with Global Initiative for Chron...

The inevitable drift to triple therapy in COPD: An analysis of prescribing pathways in the UK

Brusselle, G.G. (Guy)
Price, D. (David)
Gruffydd-Jones, K. (Kevin)
Miravitlles, M. (Marc)
Keininger, D.L. (Dorothy L.)
Stewart, R. (Rebecca)
Baldwin, M. (Michael)
Jones, R.C. (Rupert C.)

January 2015

Background: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid ...

Changes in COPD inhaler prescriptions in the United Kingdom, 2000 to 2016

Bloom, C
Elkin, S
Quint, JK

December 2018

Background: Over the past two decades, there have been significant changes in the pharmacological ma...

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world study

Abstract

Extracted data

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : a real-world study

Abstract

Extracted data

Related items

Related items